Before setting up BenevolentAI Mulvany was CEO of Proximagen, a UK-listed biotech specialising in neurodegenerative diseases that was sold to Upsher-Smith Laboratories for $553 million in 2012.

CDMOs and CROs share their most recent business highlights from the past twelve months on the oral solid dosage front.

While FMS has specialized in the design, installation, and maintenance of environmental monitoring systems, Trescal’s focus has been on calibration and metrology services. The deal is being made for ...

Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days ...

The table is limited by our hospital pharmacy's formulary; however, our purpose was to update the current literature. The table is intended for use as a guide when medications labeled for ...